Compile Data Set for Download or QSAR
Report error Found 19 Enz. Inhib. hit(s) with all data for entry = 10765
TargetIndoleamine 2,3-dioxygenase 1(Human)
Auckland Uniservices

US Patent
LigandChemical structure of BindingDB Monomer ID 477107BDBM477107(US10888567, Compound 3 | US11414428, Compound 1 | ...)
Affinity DataIC50: 5.50E+3nMAssay Description:Recombinant human IDO1 (rhIDO1) was expressed and purified from cultures of EC538 strain of E. coli transformed with pREP4 and pQE9-IDO plasmid. Reac...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/30/2022
Entry Details
US Patent

TargetIndoleamine 2,3-dioxygenase 1(Human)
Auckland Uniservices

US Patent
LigandChemical structure of BindingDB Monomer ID 565420BDBM565420(US11414428, Compound 4)
Affinity DataIC50: 5.50E+3nMAssay Description:Recombinant human IDO1 (rhIDO1) was expressed and purified from cultures of EC538 strain of E. coli transformed with pREP4 and pQE9-IDO plasmid. Reac...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/30/2022
Entry Details
US Patent

TargetIndoleamine 2,3-dioxygenase 1(Human)
Auckland Uniservices

US Patent
LigandChemical structure of BindingDB Monomer ID 565419BDBM565419(US11414428, Compound 3)
Affinity DataIC50: 5.50E+4nMAssay Description:Recombinant human IDO1 (rhIDO1) was expressed and purified from cultures of EC538 strain of E. coli transformed with pREP4 and pQE9-IDO plasmid. Reac...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/30/2022
Entry Details
US Patent

TargetIndoleamine 2,3-dioxygenase 1(Human)
Auckland Uniservices

US Patent
LigandChemical structure of BindingDB Monomer ID 565432BDBM565432(US11414428, Compound 17 | US20250186410, Compound ...)
Affinity DataIC50: 5.50E+4nMAssay Description:Recombinant human IDO1 (rhIDO1) was expressed and purified from cultures of EC538 strain of E. coli transformed with pREP4 and pQE9-IDO plasmid. Reac...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/30/2022
Entry Details
US Patent

TargetIndoleamine 2,3-dioxygenase 1(Human)
Auckland Uniservices

US Patent
LigandChemical structure of BindingDB Monomer ID 565426BDBM565426(US11414428, Compound 11)
Affinity DataIC50: 5.50E+4nMAssay Description:Recombinant human IDO1 (rhIDO1) was expressed and purified from cultures of EC538 strain of E. coli transformed with pREP4 and pQE9-IDO plasmid. Reac...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/30/2022
Entry Details
US Patent

TargetIndoleamine 2,3-dioxygenase 1(Human)
Auckland Uniservices

US Patent
LigandChemical structure of BindingDB Monomer ID 565418BDBM565418(US11414428, Compound 2)
Affinity DataIC50: 1.00E+5nMAssay Description:Recombinant human IDO1 (rhIDO1) was expressed and purified from cultures of EC538 strain of E. coli transformed with pREP4 and pQE9-IDO plasmid. Reac...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/30/2022
Entry Details
US Patent

TargetIndoleamine 2,3-dioxygenase 1(Human)
Auckland Uniservices

US Patent
LigandChemical structure of BindingDB Monomer ID 565422BDBM565422(US11414428, Compound 7)
Affinity DataIC50: 1.00E+5nMAssay Description:Recombinant human IDO1 (rhIDO1) was expressed and purified from cultures of EC538 strain of E. coli transformed with pREP4 and pQE9-IDO plasmid. Reac...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/30/2022
Entry Details
US Patent

TargetIndoleamine 2,3-dioxygenase 1(Human)
Auckland Uniservices

US Patent
LigandChemical structure of BindingDB Monomer ID 565423BDBM565423(US11414428, Compound 8)
Affinity DataIC50: 1.00E+5nMAssay Description:Recombinant human IDO1 (rhIDO1) was expressed and purified from cultures of EC538 strain of E. coli transformed with pREP4 and pQE9-IDO plasmid. Reac...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/30/2022
Entry Details
US Patent

TargetIndoleamine 2,3-dioxygenase 1(Human)
Auckland Uniservices

US Patent
LigandChemical structure of BindingDB Monomer ID 565421BDBM565421(US11414428, Compound 6)
Affinity DataIC50: 1.00E+5nMAssay Description:Recombinant human IDO1 (rhIDO1) was expressed and purified from cultures of EC538 strain of E. coli transformed with pREP4 and pQE9-IDO plasmid. Reac...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/30/2022
Entry Details
US Patent

TargetIndoleamine 2,3-dioxygenase 1(Human)
Auckland Uniservices

US Patent
LigandChemical structure of BindingDB Monomer ID 565427BDBM565427(US11414428, Compound 12)
Affinity DataIC50: 1.00E+5nMAssay Description:Recombinant human IDO1 (rhIDO1) was expressed and purified from cultures of EC538 strain of E. coli transformed with pREP4 and pQE9-IDO plasmid. Reac...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/30/2022
Entry Details
US Patent

TargetIndoleamine 2,3-dioxygenase 1(Human)
Auckland Uniservices

US Patent
LigandChemical structure of BindingDB Monomer ID 565424BDBM565424(US11414428, Compound 9)
Affinity DataIC50: 1.00E+5nMAssay Description:Recombinant human IDO1 (rhIDO1) was expressed and purified from cultures of EC538 strain of E. coli transformed with pREP4 and pQE9-IDO plasmid. Reac...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/30/2022
Entry Details
US Patent

TargetIndoleamine 2,3-dioxygenase 1(Human)
Auckland Uniservices

US Patent
LigandChemical structure of BindingDB Monomer ID 565425BDBM565425(US11414428, Compound 10)
Affinity DataIC50: 1.00E+5nMAssay Description:Recombinant human IDO1 (rhIDO1) was expressed and purified from cultures of EC538 strain of E. coli transformed with pREP4 and pQE9-IDO plasmid. Reac...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/30/2022
Entry Details
US Patent

TargetIndoleamine 2,3-dioxygenase 1(Human)
Auckland Uniservices

US Patent
LigandChemical structure of BindingDB Monomer ID 565430BDBM565430(US11414428, Compound 15 | US20250186410, Compound ...)
Affinity DataIC50: 1.00E+5nMAssay Description:Recombinant human IDO1 (rhIDO1) was expressed and purified from cultures of EC538 strain of E. coli transformed with pREP4 and pQE9-IDO plasmid. Reac...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/30/2022
Entry Details
US Patent

TargetIndoleamine 2,3-dioxygenase 1(Human)
Auckland Uniservices

US Patent
LigandChemical structure of BindingDB Monomer ID 565431BDBM565431(US11414428, Compound 16)
Affinity DataIC50: 1.00E+5nMAssay Description:Recombinant human IDO1 (rhIDO1) was expressed and purified from cultures of EC538 strain of E. coli transformed with pREP4 and pQE9-IDO plasmid. Reac...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/30/2022
Entry Details
US Patent

TargetIndoleamine 2,3-dioxygenase 1(Human)
Auckland Uniservices

US Patent
LigandChemical structure of BindingDB Monomer ID 565428BDBM565428(US11414428, Compound 13)
Affinity DataIC50: 1.00E+5nMAssay Description:Recombinant human IDO1 (rhIDO1) was expressed and purified from cultures of EC538 strain of E. coli transformed with pREP4 and pQE9-IDO plasmid. Reac...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/30/2022
Entry Details
US Patent

TargetIndoleamine 2,3-dioxygenase 1(Human)
Auckland Uniservices

US Patent
LigandChemical structure of BindingDB Monomer ID 565429BDBM565429(US11414428, Compound 14)
Affinity DataIC50: 1.00E+5nMAssay Description:Recombinant human IDO1 (rhIDO1) was expressed and purified from cultures of EC538 strain of E. coli transformed with pREP4 and pQE9-IDO plasmid. Reac...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/30/2022
Entry Details
US Patent

TargetIndoleamine 2,3-dioxygenase 1(Human)
Auckland Uniservices

US Patent
LigandChemical structure of BindingDB Monomer ID 565434BDBM565434(US11414428, Compound 19)
Affinity DataIC50: 1.00E+5nMAssay Description:Recombinant human IDO1 (rhIDO1) was expressed and purified from cultures of EC538 strain of E. coli transformed with pREP4 and pQE9-IDO plasmid. Reac...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/30/2022
Entry Details
US Patent

TargetIndoleamine 2,3-dioxygenase 1(Human)
Auckland Uniservices

US Patent
LigandChemical structure of BindingDB Monomer ID 565435BDBM565435(US11414428, Compound 20)
Affinity DataIC50: 1.00E+5nMAssay Description:Recombinant human IDO1 (rhIDO1) was expressed and purified from cultures of EC538 strain of E. coli transformed with pREP4 and pQE9-IDO plasmid. Reac...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/30/2022
Entry Details
US Patent

TargetIndoleamine 2,3-dioxygenase 1(Human)
Auckland Uniservices

US Patent
LigandChemical structure of BindingDB Monomer ID 565433BDBM565433(US11414428, Compound 18)
Affinity DataIC50: 1.00E+5nMAssay Description:Recombinant human IDO1 (rhIDO1) was expressed and purified from cultures of EC538 strain of E. coli transformed with pREP4 and pQE9-IDO plasmid. Reac...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/30/2022
Entry Details
US Patent